Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1325 USD | +2.32% | +1.92% | -5.36% |
Financials (USD)
Sales 2022 | 32.26M | Sales 2023 | 34.16M | Capitalization | 29.4M |
---|---|---|---|---|---|
Net income 2022 | 8M | Net income 2023 | 3M | EV / Sales 2022 | 0.92 x |
Net cash position 2022 | 5.75M | Net cash position 2023 | 3.94M | EV / Sales 2023 | 0.75 x |
P/E ratio 2022 |
4.73
x | P/E ratio 2023 |
9.34
x | Employees | 53 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.76% |
Latest transcript on Elite Pharmaceuticals, Inc.
1 day | +2.32% | ||
1 week | +1.92% | ||
Current month | -14.13% | ||
1 month | -13.40% | ||
3 months | -30.26% | ||
6 months | +12.48% | ||
Current year | -5.36% |
Managers | Title | Age | Since |
---|---|---|---|
Nasrat Hakim
CEO | Chief Executive Officer | 63 | 13-07-31 |
Carter Ward
DFI | Director of Finance/CFO | 59 | 09-06-30 |
Christopher Dick
PSD | President | 69 | 02-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Whitnell
BRD | Director/Board Member | 68 | 09-10-22 |
Barry Dash
BRD | Director/Board Member | 93 | 05-03-31 |
Davis Caskey
BRD | Director/Board Member | 76 | 16-04-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.1325 | +2.32% | 290,097 |
24-04-25 | 0.1295 | +2.53% | 215,550 |
24-04-24 | 0.1263 | +2.52% | 1,124,880 |
24-04-23 | 0.1232 | -3.14% | 798,573 |
24-04-22 | 0.1272 | -2.15% | 611,836 |
Delayed Quote OTC Markets, April 26, 2024 at 03:59 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-5.36% | 142M | |
+19.62% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+13.07% | 13.64B | |
+37.46% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- ELTP Stock